Andrew Cooper
Stock Analyst at Raymond James
(3.30)
# 1,047
Out of 5,090 analysts
151
Total ratings
47.01%
Success rate
2.42%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Outperform | $35 → $45 | $35.05 | +28.39% | 3 | Nov 25, 2025 | |
| ITGR Integer Holdings | Reiterates: Outperform | $143 → $95 | $69.84 | +36.03% | 4 | Oct 24, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | n/a | $74.97 | - | 13 | Oct 22, 2025 | |
| AVTR Avantor | Maintains: Outperform | $14 → $16 | $10.93 | +46.39% | 16 | Oct 16, 2025 | |
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $83.94 | -7.08% | 10 | Aug 11, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $102.02 | -40.21% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $100.79 | +14.10% | 9 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $572.77 | -6.59% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $7.09 | +41.04% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $27.79 | -10.04% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $217.14 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $226.25 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $101.06 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.53 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $244.55 | -65.24% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $27.76 | +173.78% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.99 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.90 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $44.61 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.49 | - | 5 | Sep 22, 2021 |
Azenta
Nov 25, 2025
Maintains: Outperform
Price Target: $35 → $45
Current: $35.05
Upside: +28.39%
Integer Holdings
Oct 24, 2025
Reiterates: Outperform
Price Target: $143 → $95
Current: $69.84
Upside: +36.03%
Hologic
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $74.97
Upside: -
Avantor
Oct 16, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $10.93
Upside: +46.39%
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $83.94
Upside: -7.08%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $102.02
Upside: -40.21%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $100.79
Upside: +14.10%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $572.77
Upside: -6.59%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $7.09
Upside: +41.04%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $27.79
Upside: -10.04%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $217.14
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $226.25
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $101.06
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $18.53
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $244.55
Upside: -65.24%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $27.76
Upside: +173.78%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $4.99
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $11.90
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $44.61
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.49
Upside: -